Recap: Conmed Q1 Earnings

Shares of Conmed CNMD rose in after-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share increased 23.53% over the past year to $0.63, which beat the estimate of $0.44.

Revenue of $232,677,000 rose by 8.72% year over year, which beat the estimate of $216,880,000.

Looking Ahead

The upcoming fiscal year's EPS expected to be between $3.05 and $3.20.

The upcoming fiscal year's revenue expected to be between $1,000,000,000 and $1,030,000,000.

Details Of The Call

Date: Apr 28, 2021

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/zqty4c9q

Technicals

52-week high: $136.55

52-week low: $60.65

Price action over last quarter: Up 19.85%

Company Profile

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!